• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimizing salvage radiotherapy in prostate cancer: the emerging role of prostate-specific membrane antigen positron emission tomography/computed tomography.

作者信息

Gonzalez Del Portillo Elísabet, López-Campos Fernando, Sargos Paul, Couñago Felipe

机构信息

Department of Radiation Oncology, Hospital Universitario La Paz, Madrid, Spain.

Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

出版信息

Transl Androl Urol. 2025 May 30;14(5):1182-1186. doi: 10.21037/tau-2025-188. Epub 2025 May 19.

DOI:10.21037/tau-2025-188
PMID:40529015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12170276/
Abstract
摘要

相似文献

1
Optimizing salvage radiotherapy in prostate cancer: the emerging role of prostate-specific membrane antigen positron emission tomography/computed tomography.优化前列腺癌挽救性放疗：前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描的新作用
Transl Androl Urol. 2025 May 30;14(5):1182-1186. doi: 10.21037/tau-2025-188. Epub 2025 May 19.
2
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774).前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描对前列腺癌挽救性放疗管理的影响：一项前瞻性多中心随机 3 期试验（PSMA-SRT NCT03582774）的结果。
Eur Urol. 2024 Jul;86(1):52-60. doi: 10.1016/j.eururo.2024.01.012. Epub 2024 Jan 29.
3
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描与挽救性放疗治疗生化复发前列腺癌患者的肿瘤学结局改善相关。
Eur Urol Oncol. 2022 Apr;5(2):146-152. doi: 10.1016/j.euo.2022.01.001. Epub 2022 Jan 22.
4
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following Prostatectomy.前列腺切除术后前列腺特异性膜抗原正电子发射断层扫描引导下的挽救性放疗后更好的肿瘤学结局
Eur Urol Focus. 2024 Nov 27. doi: 10.1016/j.euf.2024.11.006.
5
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study.基于机器学习的方法预测根治性前列腺切除术后复发前列腺癌 PSMA-PET 引导挽救性放疗后生化结局：回顾性研究。
JMIR Cancer. 2024 Sep 20;10:e60323. doi: 10.2196/60323.
6
Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups.根治性前列腺切除术后根据前列腺特异性膜抗原正电子发射断层扫描和欧洲泌尿外科学会生化复发风险组的无事件生存。
BJU Int. 2022 Nov;130 Suppl 3(Suppl 3):32-39. doi: 10.1111/bju.15762. Epub 2022 Jul 12.
7
Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.一种新型列线图的开发与内部验证，该列线图用于预测在重新分期的前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描中无转移的前列腺癌根治术后生化复发患者挽救性放射治疗的结果。
Eur Urol Open Sci. 2024 Feb 6;61:37-43. doi: 10.1016/j.euros.2024.01.009. eCollection 2024 Mar.
8
Prognostic significance of a negative PSMA PET/CT in biochemical recurrence of prostate cancer.PSMA PET/CT 阴性对前列腺癌生化复发的预后意义。
Cancer Imaging. 2024 Aug 30;24(1):117. doi: 10.1186/s40644-024-00752-1.
9
Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences.在达到前列腺癌放疗后生化复发的凤凰城标准之前进行前列腺特异性膜抗原正电子发射断层扫描：更早检测复发
Eur Urol Oncol. 2025 Apr;8(2):417-424. doi: 10.1016/j.euo.2024.09.015. Epub 2024 Oct 16.
10
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy.前列腺切除术治疗后复发或持续性前列腺癌行 PSMA-PET 引导挽救性放疗后的无转移生存和远处转移疾病模式。
Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1015-1024. doi: 10.1016/j.ijrobp.2022.04.048. Epub 2022 Jun 3.

本文引用的文献

1
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials.预测前列腺癌放疗的剂量反应：在随机III期NRG/RTOG 0126和SAKK 09/10试验中验证一种辐射特征
Ann Oncol. 2025 May;36(5):572-582. doi: 10.1016/j.annonc.2025.01.017. Epub 2025 Feb 13.
2
Association of Free-to-Total PSA Ratio and F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study.根治性前列腺切除术后生化复发患者游离前列腺特异性抗原与 F-DCFPyL 前列腺特异性膜抗原 PET/CT 表现的相关性：一项前瞻性单中心研究。
J Nucl Med. 2024 Nov 1;65(11):1731-1739. doi: 10.2967/jnumed.124.267877.
3
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database.前列腺癌根治术后挽救性放疗中有无激素治疗的预后因素：ICECaP 数据库中随机试验的个体患者数据分析。
Radiother Oncol. 2024 Dec;201:110532. doi: 10.1016/j.radonc.2024.110532. Epub 2024 Sep 13.
4
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.联合 PSMA-PET 和 PROMISE 重新定义前列腺癌患者的疾病分期和风险：一项多中心回顾性研究。
Lancet Oncol. 2024 Sep;25(9):1188-1201. doi: 10.1016/S1470-2045(24)00326-7. Epub 2024 Jul 29.
5
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-ISUP-SIOG 前列腺癌指南-2024 更新。第一部分：筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2024 Aug;86(2):148-163. doi: 10.1016/j.eururo.2024.03.027. Epub 2024 Apr 13.
6
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy.欧洲泌尿外科学会风险分层预测了接受 PSMA-PET 计划挽救性放疗的根治性前列腺切除术后生化复发患者的结局。
Radiother Oncol. 2024 May;194:110215. doi: 10.1016/j.radonc.2024.110215. Epub 2024 Mar 7.
7
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774).前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描对前列腺癌挽救性放疗管理的影响：一项前瞻性多中心随机 3 期试验（PSMA-SRT NCT03582774）的结果。
Eur Urol. 2024 Jul;86(1):52-60. doi: 10.1016/j.eururo.2024.01.012. Epub 2024 Jan 29.
8
Up-to-Date Imaging and Diagnostic Techniques for Prostate Cancer: A Literature Review.前列腺癌的最新成像与诊断技术：文献综述
Diagnostics (Basel). 2023 Jul 5;13(13):2283. doi: 10.3390/diagnostics13132283.
9
Phase III Study of F-PSMA-1007 Versus F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study.F-PSMA-1007 与 F-氟代胆碱 PET/CT 用于前列腺癌生化复发定位的 III 期研究：一项前瞻性、随机、交叉多中心研究。
J Nucl Med. 2023 Apr;64(4):579-585. doi: 10.2967/jnumed.122.264743. Epub 2022 Nov 23.
10
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.雄激素剥夺治疗和盆腔淋巴结治疗联合前列腺床挽救性放疗（NRG Oncology/RTOG 0534 SPORT）：一项国际、多中心、随机 3 期试验。
Lancet. 2022 May 14;399(10338):1886-1901. doi: 10.1016/S0140-6736(21)01790-6.